| Original language | English |
|---|---|
| Pages (from-to) | 1465-1466 |
| Number of pages | 2 |
| Journal | JAMA |
| Volume | 324 |
| Issue number | 14 |
| DOIs |
|
| State | Published - 13 Oct 2020 |
All Science Journal Classification (ASJC) codes
- General Medicine
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: JAMA, Vol. 324, No. 14, 13.10.2020, p. 1465-1466.
Research output: Contribution to journal › Comment/debate
TY - JOUR
T1 - Replicability of Treatment Effect in Study of Blood Pressure Lowering With Dementia
AU - Panagiotou, Orestis A.
AU - Jaljuli, Iman
AU - Heller, Ruth
N1 - Funding Information: Conflict of Interest Disclosures: Dr Judge reported receiving grants from the Irish Clinical Academic Training Programme, the Wellcome Trust, the Health Research Board, the Health Service Executive, National Doctors Training and Planning, and the Health and Social Care, Research and Development Division, Northern Ireland. No other disclosures were reported. Funding Information: Conflict of Interest Disclosures: Dr Panagiotou reported receiving a grant from the Agency for Healthcare Research and Quality. Ms Jaljuli reported receiving a grant from the US-Israel Binational Science Foundation and the National Science Foundation. Dr Heller reported receiving a grant from the Israeli Science Foundation. 1. Hughes D, Judge C, Murphy R, et al. Association of blood pressure lowering with incident dementia or cognitive impairment: a systematic review and meta-analysis. JAMA. 2020;323(19):1934-1944. doi:10.1001/jama.2020.4249 2. US Food and Drug Administration. Guidance for Industry: Providing Clinical Evidence of Effectiveness for Human Drugs and Biological Products. US Food and Drug Administration; 1998. 3. Wang J, Owen AB. Admissibility in partial conjunction testing. J Am Stat Assoc. 2019;114(525):158-168. doi:10.1080/01621459.2017.1385465 4. Benjamini Y, Heller R. Screening for partial conjunction hypotheses. Biometrics. 2008;64(4):1215-1222. doi:10.1111/j.1541-0420.2007.00984.x Funding Information: Conflict of Interest Disclosures: Dr Pais reported receiving grants from the American Urological Association and having financial investments and equity in Sonomotion, a lithotripsy company. No other disclosures were reported.
PY - 2020/10/13
Y1 - 2020/10/13
UR - http://www.scopus.com/inward/record.url?scp=85092885533&partnerID=8YFLogxK
U2 - 10.1001/jama.2020.14871
DO - 10.1001/jama.2020.14871
M3 - تعليقَ / نقاش
C2 - 33048147
SN - 0002-9955
VL - 324
SP - 1465
EP - 1466
JO - JAMA
JF - JAMA
IS - 14
ER -